Access to ABBV-787 Before Official Approval

Sponsor: AbbVie

Expanded Access
Sponsor score: 60
Inactive

ClinicalTrials ID:NCT06439966

Provider View

This program allows certain patients to access the drug ABBV-787 before it is officially approved by health authorities. A doctor will determine if the potential benefits of taking this investigational drug outweigh the risks for each patient.

Patient Parameters

Program Overview

This program is designed to provide access to the drug ABBV-787 for patients who may benefit from it before it receives official approval. The availability of this drug will depend on the rules in different regions. A doctor will evaluate each patient's medical history to decide if the benefits of taking ABBV-787 are greater than the risks involved.

Eligibility Criteria

Inclusion Criteria

  • The participant must not qualify for any ongoing clinical trials involving ABBV-787.

Get This Program In Your Inbox

Receive detailed information about this treatment opportunity to review with your healthcare provider.